Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin

The incorporation of both nitric oxide (NO) donor (S-nitrosoglutathione, GSNO) and silica nanoparticles loaded with cisplatin (SiO<sub>2</sub>@CisPt NPs) into a polymeric matrix represents a suitable approach to creating a drug-delivery system with sustained and localized drug release ag...

Full description

Bibliographic Details
Main Authors: Bianca de Melo Santana, Joana Claudio Pieretti, Rafael Nunes Gomes, Giselle Cerchiaro, Amedea Barozzi Seabra
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/12/2837
_version_ 1827637234083299328
author Bianca de Melo Santana
Joana Claudio Pieretti
Rafael Nunes Gomes
Giselle Cerchiaro
Amedea Barozzi Seabra
author_facet Bianca de Melo Santana
Joana Claudio Pieretti
Rafael Nunes Gomes
Giselle Cerchiaro
Amedea Barozzi Seabra
author_sort Bianca de Melo Santana
collection DOAJ
description The incorporation of both nitric oxide (NO) donor (S-nitrosoglutathione, GSNO) and silica nanoparticles loaded with cisplatin (SiO<sub>2</sub>@CisPt NPs) into a polymeric matrix represents a suitable approach to creating a drug-delivery system with sustained and localized drug release against tumor cells. Herein, we report the synthesis, characterization, and cytotoxicity evaluation of Pluronic F-127/hyaluronic acid hydrogel containing GSNO and SiO<sub>2</sub>@CisPt NPs against breast cancer cells. SiO<sub>2</sub>@CisPt NPs were successfully synthesized, revealing a spherical morphology with an average size of 158 ± 20 nm. Both GSNO and SiO<sub>2</sub>@CisPt NPs were incorporated into the thermoresponsive Pluronic/hyaluronic hydrogel for sustained and localized release of both NO and cisplatin. The kinetics of NO release from a hydrogel matrix revealed spontaneous and sustained release of NO at the millimolar range for 24 h. The MTT assay showed concentration-dependent cytotoxicity of the hydrogel. The combination of GSNO and SiO<sub>2</sub>@CisPt incorporated into a polymeric matrix decreased the cell viability 20% more than the hydrogel containing only GSNO or SiO<sub>2</sub>@CisPt. At 200 µg/mL, this combination led to a critical cell viability of 30%, indicating a synergistic effect between GSNO and SiO<sub>2</sub>@CisPt NPs in the hydrogel matrix, and, therefore, highlighting the potential application of this drug-delivery system in the field of biomedicine.
first_indexed 2024-03-09T15:57:29Z
format Article
id doaj.art-7a36fe6c46464d71895be7aa13ead46b
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T15:57:29Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-7a36fe6c46464d71895be7aa13ead46b2023-11-24T17:22:52ZengMDPI AGPharmaceutics1999-49232022-12-011412283710.3390/pharmaceutics14122837Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with CisplatinBianca de Melo Santana0Joana Claudio Pieretti1Rafael Nunes Gomes2Giselle Cerchiaro3Amedea Barozzi Seabra4Center for Natural and Human Sciences, Federal University of ABC, Santo André 09210-580, BrazilCenter for Natural and Human Sciences, Federal University of ABC, Santo André 09210-580, BrazilCenter for Natural and Human Sciences, Federal University of ABC, Santo André 09210-580, BrazilCenter for Natural and Human Sciences, Federal University of ABC, Santo André 09210-580, BrazilCenter for Natural and Human Sciences, Federal University of ABC, Santo André 09210-580, BrazilThe incorporation of both nitric oxide (NO) donor (S-nitrosoglutathione, GSNO) and silica nanoparticles loaded with cisplatin (SiO<sub>2</sub>@CisPt NPs) into a polymeric matrix represents a suitable approach to creating a drug-delivery system with sustained and localized drug release against tumor cells. Herein, we report the synthesis, characterization, and cytotoxicity evaluation of Pluronic F-127/hyaluronic acid hydrogel containing GSNO and SiO<sub>2</sub>@CisPt NPs against breast cancer cells. SiO<sub>2</sub>@CisPt NPs were successfully synthesized, revealing a spherical morphology with an average size of 158 ± 20 nm. Both GSNO and SiO<sub>2</sub>@CisPt NPs were incorporated into the thermoresponsive Pluronic/hyaluronic hydrogel for sustained and localized release of both NO and cisplatin. The kinetics of NO release from a hydrogel matrix revealed spontaneous and sustained release of NO at the millimolar range for 24 h. The MTT assay showed concentration-dependent cytotoxicity of the hydrogel. The combination of GSNO and SiO<sub>2</sub>@CisPt incorporated into a polymeric matrix decreased the cell viability 20% more than the hydrogel containing only GSNO or SiO<sub>2</sub>@CisPt. At 200 µg/mL, this combination led to a critical cell viability of 30%, indicating a synergistic effect between GSNO and SiO<sub>2</sub>@CisPt NPs in the hydrogel matrix, and, therefore, highlighting the potential application of this drug-delivery system in the field of biomedicine.https://www.mdpi.com/1999-4923/14/12/2837nitric oxidenanoparticleshydrogelcytotoxicitydrug deliverybreast cancer cells
spellingShingle Bianca de Melo Santana
Joana Claudio Pieretti
Rafael Nunes Gomes
Giselle Cerchiaro
Amedea Barozzi Seabra
Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
Pharmaceutics
nitric oxide
nanoparticles
hydrogel
cytotoxicity
drug delivery
breast cancer cells
title Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
title_full Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
title_fullStr Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
title_full_unstemmed Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
title_short Cytotoxicity towards Breast Cancer Cells of Pluronic F-127/Hyaluronic Acid Hydrogel Containing Nitric Oxide Donor and Silica Nanoparticles Loaded with Cisplatin
title_sort cytotoxicity towards breast cancer cells of pluronic f 127 hyaluronic acid hydrogel containing nitric oxide donor and silica nanoparticles loaded with cisplatin
topic nitric oxide
nanoparticles
hydrogel
cytotoxicity
drug delivery
breast cancer cells
url https://www.mdpi.com/1999-4923/14/12/2837
work_keys_str_mv AT biancademelosantana cytotoxicitytowardsbreastcancercellsofpluronicf127hyaluronicacidhydrogelcontainingnitricoxidedonorandsilicananoparticlesloadedwithcisplatin
AT joanaclaudiopieretti cytotoxicitytowardsbreastcancercellsofpluronicf127hyaluronicacidhydrogelcontainingnitricoxidedonorandsilicananoparticlesloadedwithcisplatin
AT rafaelnunesgomes cytotoxicitytowardsbreastcancercellsofpluronicf127hyaluronicacidhydrogelcontainingnitricoxidedonorandsilicananoparticlesloadedwithcisplatin
AT gisellecerchiaro cytotoxicitytowardsbreastcancercellsofpluronicf127hyaluronicacidhydrogelcontainingnitricoxidedonorandsilicananoparticlesloadedwithcisplatin
AT amedeabarozziseabra cytotoxicitytowardsbreastcancercellsofpluronicf127hyaluronicacidhydrogelcontainingnitricoxidedonorandsilicananoparticlesloadedwithcisplatin